Article Details
Retrieved on: 2021-01-25 12:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(OTCQB:MATN) (“Mateon”), a leading developer of TGF-β therapeutics for oncology and infectious diseases, announced that it will be launching its ...
Article found on: www.globenewswire.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here